Equity

F&O

MF

Open an Account

Equity Analysis

Company Profile

Key Financial Ratios

Bharat Immunological & Biological Corporation Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524663

INE994B01014

-7.5352246

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

0

100.35

EPS(TTM)

Face Value()

Div & Yield %:

0

10

0

Particulars	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Debt-Equity Ratio	0.00	0.00	1.33	0.69	0.47
Long Term Debt-Equity Ratio	0.00	0.00	0.00	0.00	0.00
Current Ratio	0.76	0.85	0.98	1.14	1.51
Fixed Assets	0.97	2.62	9.25	12.80	14.05
Inventory	2.37	3.15	2.62	2.02	10.35
Debtors	5.94	137.53	9.69	1.48	1.88
Interest Cover Ratio	-2.24	-0.73	-4.05	-1.99	-2.69
PBIDTM (%)	-35.10	-4.94	-22.48	-13.79	-6.10
PBITM (%)	-35.44	-5.20	-22.76	-14.15	-6.43
PBDTM (%)	-50.91	-12.08	-28.09	-20.90	-8.49
CPM (%)	-37.91	-10.89	-20.94	-14.92	-6.59
APATM (%)	-38.24	-11.16	-21.22	-15.28	-6.92
ROCE (%)	0.00	0.00	0.00	0.00	0.00
RONW (%)	0.00	0.00	0.00	0.00	0.00